Panacea Index Logo

Command Palette

Search for a command to run...

Laughter yoga as an enjoyable therapeutic approach for glycemic control in individuals with type 2 diabetes: A randomized controlled trial.

Frontiers in endocrinology
May 5, 2023
Mayumi Hirosaki et al. (11 authors)
Randomized Controlled TrialJournal ArticleResearch Support, Non-U.S. Gov'tHuman StudyClinical
Study Details

Study Goal

The researchers aimed to determine whether a 12-week laughter yoga program could improve glycemic control in individuals with type 2 diabetes.

Results Summary

The laughter yoga group showed significant improvements in HbA1c levels and positive affect scores, with a trend toward increased sleep duration. The program had a high attendance rate (92.9%), indicating feasibility.

Population

42 participants with type 2 diabetes.

Effective Dosage

12-week laughter yoga program (frequency not specified).

Duration

12 weeks.

Interactions

None mentioned.

Extracted Claims (4)
InterventionDirectionEndpointPopulationDosageImpactClaim #
a 12-week laughter yoga program
decrease
HbA1c levels
individuals with type 2 diabetes
-0.31% (between-group difference)
significant improvements
#1
a 12-week laughter yoga program
increase
positive affect scores
individuals with type 2 diabetes
0.62 points (between-group difference)
significant improvements
#2
a 12-week laughter yoga program
increase
sleep duration
individuals with type 2 diabetes
0.4 hours (between-group difference)
tended to increase
#3
a 12-week laughter yoga program
neutral
-
individuals with type 2 diabetes
-
is feasible
#4
Abstract

BACKGROUND: Laughter has been reported to have various health benefits. However, data on the long-term effects of laughter interventions on diabetes are limited. This study aimed to investigate whether laughter yoga can improve glycemic control among individuals with type 2 diabetes. METHODS: In a single-center, randomized controlled trial, 42 participants with type 2 diabetes were randomly assigned to either the intervention or the control group. The intervention consisted of a 12-week laughter yoga program. Hemoglobin A1c (HbA1c), body weight, waist circumference, psychological factors, and sleep duration were evaluated at baseline and week 12. RESULTS: Intention-to-treat analysis showed that participants in the laughter yoga group experienced significant improvements in HbA1c levels (between-group difference: -0.31%; 95% CI -0.54, -0.09) and positive affect scores (between-group difference: 0.62 points; 95% CI 0.003, 1.23). Sleep duration tended to increase in the laughter yoga group with a between-group difference of 0.4 hours (95% CI -0.05, 0.86; P = 0.080). The mean attendance rate for laughter yoga program was high (92.9%). CONCLUSIONS: A 12-week laughter yoga program is feasible for individuals with type 2 diabetes and improves glycemic control. These findings suggest that having fun could be a self-care intervention. Further studies with larger numbers of participants are warranted to better evaluate the effects of laughter yoga. CLINICAL TRIAL REGISTRATION: http://www.chinadrugtrials.org.cn, identifier UMIN000047164.

Medical Subject Headings (MeSH)
HumansDiabetes Mellitus, Type 2Laughter TherapyGlycated HemoglobinGlycemic ControlBody Weight
Study Links
Quality Scores
SafetyNot Assessed
Efficacy75/10
Quality80/10
Citation Metrics
Total Citations6
Citations/Year3.0
Relative Citation Ratio1.97
NIH Percentile74%
Research Impact Scores
APT Score0.75
Weight Score2.72
Normalized Score0.66
Related Supplements